Mercer Global Advisors
GEN

Mercer Global Advisors’s Genesis Healthcare, Inc. GEN Stock Holding History

Mercer Global Advisors’s Portfolio GEN Stock Details GEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-25,000
Closed -$14K – 1407
2020
Q3 		$14K Buy
+25,000
New +$18K ﹤0.01% 1231
2020
Q2 		– Sell
-25,000
Closed -$21K – 1211
2020
Q1 		$21K Hold
25,000
– – ﹤0.01% 1081
2019
Q4 		$41K Buy
+25,000
New +$37.5K ﹤0.01% 1151

Other funds holding GEN

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
FWC
First Washington Corp Seattle, Washington $353M AUM 41.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Mercer Global Advisors's GEN Position: Q4 2020 in Review

Mercer Global Advisors sold out of Genesis Healthcare, Inc. (GEN) in Q4 2020, closing a stake of 25,000 shares — an estimated $14K sold.

Mercer Global Advisors first reported a position in GEN in Q4 2019 and held it in 3 quarters. The position peaked at $41K in Q4 2019. 49 funds tracked by Wall St. Rank hold GEN as of Q4 2020.

  • Mercer Global Advisors reported no remaining Genesis Healthcare, Inc. position as of Q4 2020 after selling out during the quarter.
  • Mercer Global Advisors sold 25,000 Genesis Healthcare, Inc. shares in Q4 2020, an estimated $14K.
  • Mercer Global Advisors first reported a position in Genesis Healthcare, Inc. in Q4 2019 and held it in 3 quarters.
  • Mercer Global Advisors's Genesis Healthcare, Inc. position peaked at $41K in Q4 2019.
  • 49 funds tracked by Wall St. Rank held Genesis Healthcare, Inc. as of Q4 2020.

Based on Mercer Global Advisors's 13F filing for Q4 2020, filed 12 Feb 2021.